Profil
Xue Dan Wu is currently Chief Executive Officer & Executive Director at Pharmesis International Ltd. since 2017 and Chairman at Sichuan Longlife Pharmaceutical Co. Ltd. Mr. Wu was Chairman & General Manager at Chengdu Kinna Pharmaceutical Co. Ltd. Mr. Wu completed an undergraduate degree at Union University in 1987.
Aktiva positioner av Xue Dan Wu
| Företag | Position | Start |
|---|---|---|
| PHARMESIS INTERNATIONAL LTD. | Verkställande Direktör | 2017-12-31 |
Sichuan Longlife Pharmaceutical Co., Ltd.
Sichuan Longlife Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Develops, manufactures and sells traditional Chinese medicines | Ordförande | - |
Tidigare kända positioner av Xue Dan Wu
| Företag | Position | Slut |
|---|---|---|
Chengdu Kinna Pharmaceutical Co., Ltd.
Chengdu Kinna Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medicines & health tonic products | Verkställande Direktör | - |
Xue Dan Wus utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Pharmesis International Ltd.
Pharmesis International Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in the manufacturing and distributing pharmaceutical products | Health Technology |
Union University
Union University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chengdu Kinna Pharmaceutical Co., Ltd.
Chengdu Kinna Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medicines & health tonic products | Health Technology |
Sichuan Longlife Pharmaceutical Co., Ltd.
Sichuan Longlife Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Develops, manufactures and sells traditional Chinese medicines | Health Technology |
















